Table 2.
Baseline clinical characteristics of T2DM patients attending JUMC, May 2016.
| Variables | Intervention mean (SD) | Comparison mean (SD) |
|---|---|---|
| Age at diagnosis (in years) | 47 (10) | 47 (10) |
| Years lived with diabetes | 10 (6) | 12 (7) |
| BMI (kg/m2) | 25 (4) | 25 (4) |
| Waist circumference (both sexes [cm]) | 93 (11) | 96 (11) |
| Waist circumference (men [cm]) | 93 (10) | 95 (10) |
| Waist circumference (women [cm]) | 94 (13) | 98 (12) |
| Waist-to-hip ratio (both sexes) | 0.96 (0.06) | 0.96 (0.09) |
| Waist-to-hip ratio (men) | 0.98 (0.06) | 0.97 (0.08) |
| Waist-to-hip ratio (women) | 0.94 (0.07) | 0.94 (0.10) |
| SBP (mmHg) | 124 (20) | 125 (19) |
| DBP (mmHg) | 79 (13) | 78 (11) |
| FBS (mg/dL) | 154 (61) | 158 (65) |
| HbA1c (%) | 11 (4) | 10 (3) |
| TYPE OF MEDICATION–FREQUENCY (%) | ||
| OHAs–frequency (%) | 73 (63) | 54 (52) |
| Insulin–frequency (%) | 31 (27) | 43 (41) |
| Both OHAs and insulin–frequency (%) | 12 (10) | 7 (7) |
BMI = weight (kg)/height (m)2.